Global Circulating Tumor Cells (CTC) Market (2021-2026) by Technology, Application, Product, Specimen, End-User, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

The Global Circulating Tumor Cells (CTC) Market is estimated to be USD 9.52 Bn in 2021 and is expected to reach USD 18.41 Bn by 2026, growing at a CAGR of 14.1%.

Market Dynamics

Key factors such as the growing incidence of cancer followed by the increasing potential of CTCs in diagnosis and treatment have been a prominent driver for the Global Circulating Tumor Cells (CTC) Market. Similarly, the shifting preference towards minimally invasive diagnostic methods and higher awareness about cancer has led to preventive initiatives taken by individuals in demand for preventive medicines.

However, factors such as lack of awareness and technical difficulties in detection are likely to restrain the market growth. Moreover, stringent government regulations and reluctance to adopt novel CTC technologies are posing to cause significant challenges for the market growth.

Market Segmentation

The Global Circulating Tumor Cells (CTC) Market is segmented further based on Technology, Application, Product, Specimen, End-User, and Geography.

By Technology, the market is classified as CTC Enrichment, CTC Detection, and CTC Analysis. Amongst all, the CTC Detection segment holds the highest market share.

By Application, the market is classified as Multiple Chromosome Abnormalities, RNA Profiling, Protein Expression, and Cellular Communication. Amongst all, the Multiple Chromosomal Abnormalities segment is estimated to hold the highest market share.

By Product, the market is classified as Devices or Systems, Kits & Reagents, and Blood Collection Tubes. Amongst all, the Devices or Systems segment accounted for the largest share in the market for CTCs.

By Specimen, the market is classified as Blood, Bone Marrow, and Other Body Fluids. Amongst all, the Blood segment holds the highest market share.

By End-user, the market is classified as Research & Academic Institutes, Hospitals & Clinics, and Diagnostic Centers. Amongst all, the Hospital & Clinics segment holds the highest market share.

By Geography, North America is projected to lead the market.

Recent Developments

1. Biocept Inc has bought its product Target Selector™ assays to the physicians for evaluating the cerebrospinal fluid (CSF) of their patients in the presence of circulating tumor cells (CTCs). 14th January 2020
2. LineaRx, a subsidiary of Applied DNA Sciences has acquired the physical assets and Intellectual Property (IP) of Vitatex Inc., a biotech company providing innovative solutions in Invasive, Circulating Tumor Cells (iCTCs).. - 8th August 2019

Company Profiles

Some of the companies covered in this report are Aviva Biosciences, Advanced Cell Diagnostics, Biocept, LungLife AI, Creatv Micro Tech, Miltenyi Biotec, Menarini Silicon Biosystems, Precision for Medicine, Qiagen, etc.

Countries Studied

• America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
• Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
• Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
• Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Circulating Tumor Cells (CTC) Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
• The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Report Highlights:

• A complete analysis of the market, including parent industry
• Important market dynamics and trends
• Market segmentation
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market